Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial

Research output: Contribution to journal › Journal article › Research › peer-review

  • Søren S Lund
  • Lise Tarnow
  • Merete Frandsen
  • Bente B Nielsen
  • Birgitte V Hansen
  • Pedersen, Oluf Borbye
  • Hans-Henrik Parving
  • Allan A Vaag
OBJECTIVES: To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN: Randomised, double blind, double dummy, parallel trial. SETTING: Secondary care in Denmark between 2003 and 2006. PARTICIPANTS: Non-obese patients (BMI
Original languageEnglish
JournalBMJ. British Medical Journal (International Ed.)
Volume339
Pages (from-to)b4324
ISSN0959-8146
Publication statusPublished - 2009

Bibliographical note

Keywords: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobin A, Glycosylated; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Treatment Outcome; Weight Gain

Export Date: 7 January 2010Source: Scopus

ID: 18765021